论文信息 - Final Results of the Pyramid 1 Study, a Phase 3 Registrational Trial of Ravidasvir (PPI-668) and Sofosbuvir in HCV Genotype-4 Patients: High Rates of Sustained Viral Clearance in Cirrhotic and Non-Cirrhotic Patients - 字舞流文

Final Results of the Pyramid 1 Study, a Phase 3 Registrational Trial of Ravidasvir (PPI-668) and Sofosbuvir in HCV Genotype-4 Patients: High Rates of Sustained Viral Clearance in Cirrhotic and Non-Cirrhotic Patients

M. Abdel-hamid | A. Gomaa | I. Waked | G. Esmat | R. Colonno | E. Deen | T. Elbaz | N. Brown | P. Vig | M. Raziky | Mahmoud AbouElKhair | M. Ashour | O. Nada | Hanaa Abdel-Maguid | Eric J. Ruby | Sherine Helmy | Alyaa Sabry | H. Gamel